Pharmaceutical

ESC 2024: Insights into RNA as therapeutic target and tool

A panel of researchers gave presentations on the clinical evidence for the role of RNA in therapy for cardiovascular conditions.

Sep 6, 2024 - 04:00
ESC 2024: Insights into RNA as therapeutic target and tool
A panel of researchers gave presentations on the clinical evidence for the role of RNA in therapy for cardiovascular conditions.
Read the original article

Tags:

Previous Article

6 Signs Of Collagen Deficiency

Next Article

ESC 2024: New PACMAN-AMI trial analysis sheds insights on Praluent efficacy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Risk adjusted net present value: What is the current va...

Mar 13, 2024

Italfarmaco secures FDA approval for Duchenne muscular dystrophy drug

Italfarmaco secures FDA approval for Duchenne muscular ...

Mar 24, 2024

STAT+: Travere kidney drug narrowly fails confirmatory trial following FDA approval

STAT+: Travere kidney drug narrowly fails confirmatory ...

Sep 22, 2023